Merck

Cancer immunotherapies turn a corner in race to megablockbuster market
Fierce Biotech
Wed, 10/2/13 - 10:54 am
cancer immunotherapy
Merck
MK-3475
nivolumab
Bristol-Myers Squibb
Roche
MPDL3280A
PDL-1
Interview with Ken Frazier about Merck reorg and layoffs
Pharmalot
Wed, 10/2/13 - 10:37 am
Kenneth Frazier
Merck
layoffs
Pharma CEOs
Big Pharma and 100,000 Jobs at Risk
Yahoo/Wall St 24-7
Wed, 10/2/13 - 10:01 am
Big Pharma
layoffs
Merck
Pfizer
Roche
GSK
AstraZeneca
Will a Drastic Workforce Reduction Get Merck Back on Track?
The Fly on the Wall
Wed, 10/2/13 - 09:59 am
Merck
layoffs
Merck drug triggers response in 24 pct of lung cancer patients
Yahoo/Reuters
Tue, 10/1/13 - 06:04 pm
Merck
MK-3475
lung cancer
3 Cancer Investing Opportunities
Seeking Alpha
Tue, 10/1/13 - 10:10 am
Merck
cancer
AstraZeneca
Bristol-Myers Squibb
MK-1775
ovarian cancer
MK-3475
melanoma
Yervoy
Merck Updates Plans for Headquarters Move in New Jersey
Yahoo
Tue, 10/1/13 - 08:39 am
Merck
Merck to Fire 8,500 Workers in Cost-Cutting R&D Shift
Bloomberg
Tue, 10/1/13 - 08:01 am
Merck
R&D
layoffs
Which Alzheimer's Fighter Will Benefit From a Boost in Federal Funding?
Motley Fool
Mon, 09/30/13 - 04:29 pm
Alzheimer's disease
LY2886721
Eli Lilly
MK-8931
Merck
bapineuzumab
JNJ
solanezumab
Gammagard
Baxter International
Time to Panic About Merck's Patent Expirations?
Motley Fool
Sun, 09/29/13 - 01:47 pm
Merck
patents
[video]Should Merck Copy Pfizer and Join the "Spinoff Club"?
Motley Fool
Sat, 09/28/13 - 12:17 pm
Merck
3 Companies at the Cutting Edge of Diabetes Research
Motley Fool
Fri, 09/27/13 - 08:18 am
diabetes
Eli Lilly
Merck
MannKind
Does Conatus Pharmaceuticals Have A Winner With Emricasan?
Seeking Alpha
Thu, 09/26/13 - 08:12 am
Conatus Pharmaceuticals
emricasan
Gilead
Merck
Pfizer
liver disease
Sunesis
apoptosis
Does Merck's R&D Program Need a Wake-Up Call?
Motley Fool
Thu, 09/26/13 - 08:09 am
R&D
Merck
drug approvals
sugammadex
Pfizer
Eli Lilly
Sanofi
AstraZeneca
A Closer Look at 4 Pharmaceutical Giants
Motley Fool
Wed, 09/25/13 - 11:02 am
Merck
Pfizer
JNJ
GSK
Lilly Bets Quality Will Pay Off in U.S. Diabetes Battle
Bloomberg
Wed, 09/25/13 - 08:41 am
Eli Lilly
diabetes
Novo Nordisk
Bristol-Myers Squibb
Merck
Insiders Are Selling Biogen Idec
Seeking Alpha
Tue, 09/24/13 - 05:57 pm
Biogen Idec
AbbVie
Amgen
Bristol-Myers Squibb
JNJ
Merck
Pfizer
Cephalon
Drug Development Risk #364: Poorly Run Clinical Trials
Motley Fool
Tue, 09/24/13 - 10:10 am
R&D
clinical trials
Merck
Vertex Pharmaceuticals
Peregrine Pharmaceuticals
JNJ
Bridion
The Pharmaceutical Industry's 10 Biggest R&D Budgets
Motley Fool
Mon, 09/23/13 - 12:02 pm
R&D
Roche
Pfizer
Merck
JNJ
Novartis
Sanofi
GSK
Eli Lilly
AstraZeneca
Bristol-Myers Squibb
Under Sedation? A Merck Setback As FDA Rejects Anesthesia Drug
Pharmalot
Mon, 09/23/13 - 09:22 am
Merck
anesthesia
FDA
Bridon
sugammadex

Pages